Novartis-linked startup launches with technology designed to remove ‘destroy’ tags on helpful proteins
Bio Pharma Dive
JULY 28, 2022
Vicinitas and its protein-stabilizing research have attracted $65 million from a group of investors that includes a16z, Deerfield and GV.
Let's personalize your content